CD209 and viral infectious disease: Due to DC-SIGN’s role in the process of viral infection and its structural complexity, many groups believe that blocking the sugar binding site, ICAM-3 epitope in the carbohydrate recognition domain (CRD) will overall inhibit DC-SIGN and not allow the virus to enter.